Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord mesenchymal stem cells (Institute of Hematology & Blood Diseases Hospital)
- Development stage
- Unknown
- Lead developer
- Institute of Hematology and Blood Diseases Hospital
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intramuscular
01
Overview
Umbilical cord mesenchymal stem cells (UC-MSCs) developed by the Institute of Hematology & Blood Diseases Hospital, China, are an allogeneic cell therapy being investigated for the treatment of peripheral arterial disease (PAD) and critical limb ischemia (CLI). These stem cells are derived from the umbilical cord and possess potent immunomodulatory, anti-inflammatory, and pro-angiogenic properties. When administered via intramuscular injection into ischemic limbs, UC-MSCs are intended to stimulate the formation of new blood vessels (angiogenesis) and improve blood flow to the affected tissues, thereby reducing pain, promoting wound healing, and preventing amputation in patients with severe arterial blockages.
- Other names
- UC-MSCsumbilical cord blood mesenchymal stem cellsUCB-MSCs
Beyond the preview
Go deeper on umbilical cord mesenchymal stem cells (Institute of Hematology & Blood Diseases Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord mesenchymal stem cells (Institute of Hematology & Blood Diseases Hospital).